Abstract
Intraepithelial lymphocytes (IEL) of the small murine bowel represent a unique population of mostly CD8+ T lymphocytes that reside within the epithelial cell layer of the intestinal mucosa. The close interaction with epithelial cells appears to be crucial for IEL survival since isolation and ex vivo culture induces massive apoptosis in this lymphocyte population. Here, we provide evidence that this form of IEL cell death may be mediated at least in part by endogenously produced glucocorticoids since adrenalectomy or treatment of mice with a glucocorticoid receptor antagonist significantly enhanced ex vivo survival of IEL. We further demonstrate that ex vivo activation of IEL induces upregulation of anti-apoptotic gene products, compensates for the lack of survival cytokines and rescues from apoptotic cell death. Thus, similar to thymocytes and T cell hybridomas, IEL survival may be regulated by the antagonistic action of TCR activation and glucocorticoids.
Similar content being viewed by others
Introduction
Intraepithelial lymphocytes are a unique population of lymphocytes whose function in the immune defense and regulation is still poorly understood. IEL of the small murine intestine comprise mostly of CD8+ T cells, and whereas in the peripheral lymphatic organs, only T cells with a CD8αβ heterodimer are found, a significant portion of IEL expresses CD8αα homodimers. Similarly, T cell receptor (TCR) γδ-expressing lymphocytes are rarely found in the spleen and lymph nodes, but represent an important population in the intestinal mucosa (reviewed in 1,2,3). Recent evidence suggests that CD8αα IEL may not originate from thymic precursors, but develop and mature directly in the intestinal mucosa in so-called cryptopatches.4
Although IEL have been suggested to play an important role in host defense, in particular in the protection of the intestinal mucosa from infection by parasites and viruses,5,6,7,8 the investigation of IEL functions has been complicated by the low survival rate of isolated ex vivo cultured IEL.9,10,11 The close association of IEL with epithelial cells of the intestinal mucosa appears to be crucial for IEL survival. Isolation of IEL from their epithelial environment and ex vivo culture leads to accelerated apoptotic cell death. This form of death-by-neglect is presumably caused by the lack of epithelial cell-derived survival factors since epithelial cell-derived cytokines, such as interleukin-7 and -15, significantly enhance IEL survival.9,11
Although IEL poorly proliferate in response to ex vivo stimulation, they exhibit potent ex vivo cytotoxicity.7,12,13 Yet, differential responses of IEL to TCR stimulation are still poorly understood. Here we now show that stimulation of IEL via TCR or by addition of phorbolmyristate acetate (PMA) and ionomycin can compensate for the lack of epithelial cell-derived survival factors and induces ex vivo survival. This enhanced survival is most likely caused by induction of anti-apoptotic gene products since IEL activation leads to enhanced expression of cellular inhibitor of apoptosis (cIAP)-1 and -2, and Bcl-xL. Our data provide further evidence that death-by-neglect of ex vivo cultured IEL may be (at least in part) caused by glucocorticoids. IEL isolated form adrenalectomized animals showed enhanced ex vivo survival. Similarly, in vivo treatment of animals with the glucocorticoid receptor antagonist RU-486 (mifepristone) resulted in reduced ex vivo apoptosis whereas in vivo treatment with glucocorticoids lead to accelerated cell death. Our data indicate that TCR stimulation and glucocorticoids exhibit antagonistic activity on IEL survival, similarly to that observed in thymocytes and T cell hybridomas.14,15
Results
Analysis of ex vivo IEL apoptosis
In this study we have analyzed the regulation of cell death and survival of murine intestinal intraepithelial lymphocytes. Figure 1A shows a typical section through the small intestine. IEL are detected between epithelial cells at the basolateral side of the epithelial cell layer. To study ex vivo survival, IEL were isolated from the epithelial cell layer of the small bowel and enriched by density centrifugation. Either freshly isolated or upon ex vivo culture, apoptotic cell death was assessed by simultaneous staining for cell surface CD8α and CD8β, and detection of phosphatidylserine exposure by Annexin V (Figure 1B).16 This methodological approach allowed comparative and quantitative analysis of early apoptosis in the two major IEL subsets, i.e. CD8αα+ and CD8αβ+ IEL. Figure 1B also shows that IEL undergoing apoptotic cell death show a characteristic reduction in cell size (FSC) and increase in light scatter (SSC). This apoptotic morphology was further confirmed by TUNEL (TdT-mediated dUTP nick end labeling) (data not shown) and fluorescence microscopy using ethidium bromide/acridine orange staining. Figure 1D shows a typical example of an apoptotic IEL with a fragmented nucleus.
Spontaneous ex vivo apoptosis of IEL is not caused by CD95 ligand or TNFα
Previous reports have shown that ex vivo cultured intestinal IEL are very susceptible to apoptotic cell death.9,10,11 Similarly, we have found that both major IEL subsets, CD8αβ+ and CD8αα+ IEL, exhibited significant apoptotic cell death already after 5 h ex vivo culture and very few cells survived overnight culture (Figure 1E, and data not shown). In different experiments, we always observed high rates of spontaneous ex vivo apoptosis of IEL (average of 11 independent experiments: 60±16% Annexin V+ cells after 6–8 h ex vivo culture). Experiments with highly purified IEL (sorted by flow cytometry) indicate that dying contaminating epithelial cells within the IEL preparation are not the underlying cause of IEL death since similar or even elevated rates of apoptosis were observed in purified vs enriched IEL, respectively (73.2±7.4% (n=6) vs 64.2±15.9% (n=12), mean±S.D.). Members of the TNF/TNF receptor family have been implicated in T lymphocyte apoptosis (reviewed in17,18,19,20). Restimulation of previously activated T cell blasts causes CD95/CD95L-dependent activation-induced cell death (AICD) which is blocked by soluble CD95-Fc fusion protein (Figure 1E),21,22,23,24 but not by neutralizing anti-TNFα (Figure 1E).25 As reported previously, freshly isolated splenic T lymphocytes were found to be relatively resistant to spontaneous and activation-induced apoptosis (Figure 1E).26 Our data, however, indicate that CD95/CD95 ligand or TNFα/TNF receptors interactions are most likely not responsible for the spontaneous ex vivo demise of IEL since antagonistic soluble CD95-Fc fusion protein or neutralizing anti-TNFα could not reverse the high rate of IEL apoptosis (Figure 1E). And, whereas restimulation of T cell blasts caused CD95/CD95L-dependent AICD, stimulation of IEL rather induced a significant reduction in ex vivo apoptosis (Figure 1E).
A role for glucocorticoids in ex vivo death-by-neglect
The underlying reason for the high rate of ex vivo IEL apoptosis is currently unclear. It has been suggested that epithelial cell-derived cytokines, such as IL-7 and IL-15, may regulate IEL survival in vivo and the lack of these survival factors may contribute to IEL apoptosis in vitro.11,27,28,29 IEL have been reported previously to be exposed to and be affected by glucocorticoids in vivo and in vitro.30,31,32 Glucocorticoids are potent inducers of apoptosis in thymocytes and mature T cells (reviewed in33). Interestingly, although glucocorticoids can induce apoptosis, they can also block AICD in T cells, as well as TCR stimulation can inhibit glucocorticoid-induced cell death.15,34,35 We therefore investigated whether in vivo generated steroids may be the trigger of this form of death-by-neglect. To test this hypothesis, we first injected mice with dexamethasone (a synthetic glucocorticoid) and analyzed IEL survival upon ex vivo culture, with or without activation. Figure 2A shows that IEL isolated from dexamethasone-treated animals exhibited a reduced survival rate ex vivo, which however, was partially reverted upon ex vivo stimulation. Spleen cells, analyzed in parallel for comparison, were found to follow a similar pattern, yet with reduced sensitivity to dexamethasone (Figure 2A).
We then further assessed whether inhibition of glucocorticoid action would reduce IEL ex vivo apoptosis. The adrenal glands are a major source of glucocorticoids and adrenalectomy should significantly reduce in vivo glucocorticoid generation. Both major subsets of IEL, CD8αα and CD8αβ, isolated from adrenalectomized animals showed enhanced ex vivo survival, compared to IEL from sham-operated mice (Figure 2B). This observation was made in three independent experiments.
Since the adrenal glands may not represent the only significant source of glucocorticoids,14 we further aimed at blocking endogenous glucocorticoid activity by in vivo administration of RU-486, a glucocorticoid receptor antagonist.36 Therefore, mice were injected with 1 or 10 mg RU-486, control diluent or 1 mg dexamethasone as positive control. IEL were isolated 4 h later and apoptosis in freshly isolated or ex vivo cultured cells was analyzed. While freshly isolated IEL from control animals and RU-486-treated animals showed only minimal Annexin V binding, cells from dexamethasone-treated animals displayed already significant phosphatidylserine flip (data not shown). Ex vivo culture of control IEL for 6 h induced high rates of apoptosis, as described above, which were further exceeded in cells isolated from dexamethasone-treated animals (Figure 2C). Interestingly, however, inhibition of glucocorticoid activity by RU-486 led to a significant enhancement of ex vivo IEL survival in both major subsets (Figure 2C). This effect of RU-486 was dose-dependent since injection of 10 mg further enhanced ex vivo IEL survival (data not shown). Thus, we conclude that ex vivo death-by-neglect is, at least in part, caused by endogenously produced glucocorticoids.
Activation induces resistance to death-by-neglect
The experiment described in Figure 1C suggested that IEL activation results in enhanced ex vivo survival, rather than induction of AICD. This may be due to the reported antagonistic action of TCR and glucocorticoids.15,34,35 In order to investigate the role of activation signals on IEL apoptosis, we stimulated IEL with increasing concentrations of plate-bound anti-CD3 antibody and analyzed IEL apoptosis after 6 h. Whereas stimulation of primed peripheral T cell blasts caused CD95/CD95L-dependent AICD (Figure 1C),22 activation of IEL led to a significant reduction in ex vivo apoptosis. Rescue from this form of death-by-neglect was dependent on the strength of stimulus since plate-bound anti-CD3 dose-dependently enhanced IEL survival (Figure 3A).
Activation induces expression of anti-apoptotic gene products
The results described above suggest that stimulation induces the expression of anti-apoptotic gene products, preventing the rapid ex vivo demise of IEL. Members of the Bcl-2 family have been previously shown to regulate lymphocyte survival, in particular death-by-neglect (reviewed in37,38). We therefore analyzed the expression of Bcl-2 and Bcl-xL by RT–PCR in freshly isolated IEL, with and without TCR stimulation, and compared expression levels to those found in spleen cells. Bcl-2 was expressed only at low levels and no significant gene induction was observed after stimulation (data not shown). In contrast, Bcl-xL was not detected in unstimulated IEL, but was efficiently induced upon IEL activation. In spleen cells, Bcl-xL was already expressed in unstimulated cells and only a minimal gene induction was observed upon TCR stimulation.
The anti-apoptotic activity of many members of the Bcl-2 family may be limited to apoptosis stimuli involving signaling via the mitochondria (reviewed in39). In contrast, cellular inhibitors of apoptosis (cIAP) act on the level of caspase activation, central signaling and execution proteases of most forms of apoptotic cell death (reviewed in40). We have therefore analyzed the expression of cIAP-1 and cIAP-2 in unstimulated and stimulated IEL. Both, cIAP-1 and -2 were hardly detectable in unstimulated IEL, however TCR triggering led to a strong induction of mRNA expression. Levels of both anti-apoptotic genes were already elevated in unstimulated spleen cells and were found unaltered upon activation (Figure 3D).
IEL stimulation prevents the degradation of apoptosis inhibitors
De novo gene induction of anti-apoptotic molecules may not represent the only mechanism how ex vivo IEL apoptosis is prevented by cell stimulation. Yang et al. have recently reported on the glucocortiocid-induced proteosome-mediated degradation of IAPs in thymocytes41. We therefore analyzed whether IAPs may be degraded during IEL apoptosis and whether stimulation antagonizes this process. cIAP-1 and XIAP (X-linked inhibitor of apoptosis)42 levels in freshly isolated IEL, or cells that were left untreated or stimulated for 3 h, were analyzed by Western blot. Surprisingly, significant protein levels of cIAP-1 and XIAP were found already in freshly isolated IEL (Figure 4A), although only minimal mRNA levels of cIAP-1 and -2 were detected in these cells (Figure 3D). Ex vivo culture for 3 h was sufficient to reduce cIAP-1 and XIAP protein to undetectable levels, suggesting glucocorticoid-induced degradation of these inhibitors of apoptosis.41 However, significant levels of cIAP-1 and XIAP were maintained if IEL were stimulated with plate-bound anti-CD3. Interestingly, while increased IEL apoptosis was already detected after 3 h ex vivo culture, no difference was observed between unstimulated and stimulated IEL (Figure 4B). However, after 5 h ex vivo culture high rates of cell death were observed in unstimulated cells, whereas apoptosis in anti-CD3 stimulated IEL was stabilized (Figure 4B). Thus, degradation of cIAP-1 and XIAP precedes detection of phosphatidylserine exposure. We further conclude that both, activation-induced gene induction as well as activation-induced prevention of degradation of inhibitors of apoptosis may contribute to ex vivo IEL survival.
Discussion
Although T lymphocytes of the intestinal epithelial cell layer represent an important number of all immune cells, their role in host defense and/or immune regulation is still largely unknown. Recent evidence, however, suggest that IEL-mediated cytotoxicity is protective during viral infections.7,8 In addition, certain subsets of IEL may represent regulatory T cells, maintaining immune homeostasis of the intestinal mucosa and oral tolerance (reviewed in43). Studies on the role of IEL in host defense and immune regulation have been complicated by the rapid demise of IEL upon ex vivo culture.9,10,11 The intimate contact of IEL with their neighboring epithelial cells appears to deliver important survival signals and dissociation of IEL from the epithelial cell layer rapidly induces apoptosis. Epithelial cells of the intestinal mucosa are a rich source of a wide variety of cytokines. For example, epithelial cells produce IL-7 and -15, two important cytokines in IEL development and survival.11,28,29 Whereas IL-7 has been described as an essential growth factor for extrathymic maturating IEL progenitors,28 IL-15 has mitogenic and survival-inducing activity in mature IEL.9,11 Similarly, targeted disruption of the common γ-chain of the IL-7 and IL-15 receptor results in reduced development of TCRγδ+ CD8αα+ IEL.44
While epithelial-derived cytokines can rescue IEL from ex vivo apoptosis,9,45 the trigger of this death-by-neglect has not been investigated so far. Our data presented here provide strong evidence that, at least in part, endogenously produced glucocorticoids may be involved in this form of apoptotic cell death. In vivo administration of dexamethasone accelerated the ex vivo demise of IEL and, similarly to spontaneous apoptotic cell death, was antagonized upon IEL activation. Furthermore, either inhibition of glucocorticoid synthesis by adrenalectomy or inhibition of glucocorticoid receptor activation by RU-486 resulted in a marked increase in IEL ex vivo survival. Although the cellular source and the kinetic of synthesis of the endogenous glucocorticoids involved in IEL apoptosis induction are unknown, we may speculate that glucocorticoids must prime IEL for apoptosis already in vivo. In vivo administration of RU-486 significantly reduced ex vivo apoptosis, whereas RU-486 added after the IEL isolation process had only minimal effect on IEL survival (data not shown). Recent studies have shown that stress or burn can lead to generation of high levels of endogenous glucocorticoids, which may trigger in vivo apoptosis of lymphocytes and IEL.30,46 Thus, euthanizing mice with CO2 could provoke sufficient stress to release glucocorticoids from the adrenal glands. On the other hand, it is possible that low levels of glucocorticoids are constitutively present in the intestinal mucosa (possibly produced by other sources than the adrenal glands?), as a negative regulatory element of the ‘physiological inflammation’ in the intestine. While adrenalectomy significantly reduced IEL apoptosis, a stronger effect was observed upon in vivo administration of RU-486. Like IEL, thymocytes are extremely sensitive to glucocorticoid-induced apoptosis. Recently, Vacchio and colleagues reported that thymic epithelial cells are an important alternative source of glucocorticoids and therefore may affect thymocyte survival.14 It is thus possible that other sources of glucocorticoids than adrenal glands, possibly even cells within the intestinal mucosa, contribute to apoptosis induction in IEL.
Glucocorticoids have been suggested to affect the transcriptional activity of NF-κB.47,48,49,50,51 Therefore, expression NF-κB-dependent survival factors52,53,54 may be antagonized by glucorticoids. Inhibition of NF-κB, by over-expression of IκB or inhibition by lactacystin, has been shown to sensitize cells to a variety of apoptosis-inducing stimuli.55,56,57 Similarly, recent evidence indicates that dexamethasone induces a proteosome-mediated degradation of cIAP-1 and XIAP in thymocytes, and subsequently apoptotic cell death.41 Our findings that ‘spontanous’ ex vivo apoptosis and dexamethasone-induced apoptosis of IEL is reduced upon TCR activation would be consistent with this model of IEL survival. TCR activation leads to strong induction of NF-κB activity and NF-κB-dependent survival genes, such as cIAP-1 and -2 (our own data).53 While in the absence of survival-promoting cytokines, endogenous glucocorticoids may induce apoptosis, IEL activation via TCR signals appears to antagonize glucocorticoid-induced death by inducing and maintaining expression of anti-apoptotic gene products. Glucocorticoids not only induce apoptosis, but may also regulate immune responses through inhibition of inflammatory cytokine production (reviewed in58,59) and cytotoxic effector functions.34,35 Thus, the controlled antagonism between glucocorticoid action and T cell activation may be important for the regulation of immune homeostasis in the intestinal mucosa.
Material and Methods
Reagents and solutions
Anti-CD8α-Cy-chrome, anti-CD8β-PE, and anti-CD4-PE were purchased from PharMingen (La Jolla, CA, USA); anti-CD3ε (145-2C11) anti-TCRαβ (H57) and anti-TCRγδ (GL-3) were purified from hybridoma supernatant by protein A columns and conjugated to FITC; neutralizing rabbit anti-mouse TNFα (IP-400) was from Genzyme (Cambridge, MA, USA) (anti-TNFα-neutralizing activity was tested in a L929 bioassay)60; Annexin V-FITC was obtained from Bender Biosystems (Vienna, Austria). The generation of soluble CD95-immunoglobulin fusion protein (sCD95-Fc) has been reported previously.22,61
Culture medium consisted of RPMI 1640, 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 ug/ml streptomycin, 50 uM β-mercaptoethanol, 20 mM HEPES pH 7.4. HEPES-buffered salt solution (HBS) consisted of 10 mM HEPES pH 7.2, 25 mM NaHCO3, 5.4 mM KCl, 0.3 mM Na2HPO4, 0.4 mM KH2PO4, 137 mM NaCl, 5.6 mM D-glucose. Percoll and Ficoll were purchased from Pharmacia (Uppsala, Sweden). Isotonic Percoll solution was made by adding 1/10 of the volume of 10 times concentrated HBS. Recombinant interleukin (IL)-2 (proleukin) was from Chiron (Suresnes, France). Concanavalin A (Con A), phorbolmyristate acetate (PMA), dexamethasone were from Sigma (St. Louis, MO, USA), ionomycin from Calbiochem (La Jolla, CA, USA).
Isolation of IEL from small intestine
Male Balb/c mice were bred and maintained in the animal facility of the Faculty of Medicine, University of Bern, Switzerland. Age-matched male adrenalectomized or sham-operated Balb/c mice were obtained from Harlan (The Nederlands). Mice were euthanized with CO2 and IEL from the small bowel of 7–10 week old mice were isolated as described previously.12,62 Briefly, epithelial cells and IEL were dissociated in HBS, 1 mM DTT and separated on a 40%/70% Percoll gradient. The interphase containing enriched IEL (usually between 40–85% CD8+ cells) was washed, resuspended in culture medium and directly used for experiments. Purified cells usually consisted of 36.6±12.6% CD8αβ+, 39.7±3.8% CD8αα+, 60.2±19.2% TCRαβ+, 23.8±7.5% TCRγδ+ lymphocytes (mean±S.D. of eight isolations) and were approximately 95% viable, as monitored by Annexin V binding.16 In some experiments, IEL were further sorted on a FACSvantage (Becton Dickinson, Mountain View, CA, USA) based on the lymphocyte gate in the forward-side scatter.
Spleen cells were isolated by meshing up the spleen between frosted microscopy glass slides and subsequent hypotonic lysis to remove erythrocytes.12 After resuspension in complete medium, cells were either directly used for experiments (spleen cells) or stimulated for 2 days with 1 ug/ml concanavalin A (Sigma) and subsequent culture with 100 U/ml recombinant IL-2 for 5 days to generate T cell blasts. Before being used in an experiment, T cell blasts were purified by Ficoll density centrifugation to remove dead cells.
Assessment of apoptosis in distinct T cell subsets
Apoptosis was assessed by the detection of phosphatidylserine on the cell surface of dying cells.16 Enriched or sorted IEL were resuspended at 5×104 or 1×105 cell per 200 ul and cultured in flat-bottom 96 well plates. If cells were treated with anti-CD3, plates were previously coated overnight with appropriate concentrations of anti-CD3 in 50 mM Tris pH 9.0 at 4°C and washed three times with PBS. Other stimuli or reagents were directly added to the cells in appropriate dilutions at 1/20 of the culture volume. Final DMSO or ethanol concentrations were always ⩽0.1%. After either 5–6 h or overnight incubation, cells were harvested, washed once with cold PBS, 1% calf serum and then stained for 20 min with anti-CD8α Cy-chrome and anti-CD8β PE at 4°C. Cells were subsequently washed with Annexin V binding buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2) and then stained with Annexin V-FITC (0.5 ug/ml) for 5 min. After two washes with Annexin V binding buffer, cells were fixed in 1% paraformaldehyde in Annexin V binding buffer and analyzed on a FACScan flow cytometer using Cellquest analysis software (Becton Dickinson, Mountain View, CA, USA). Cells in the lymphocyte gate were analyzed for their expression of CD8α and CD8β, and CD8αα+ or CD8αβ+ populations were examined for cell death by means of their Annexin V staining.
For comparison, freshly isolated spleen cells or day 7 T cell blasts were treated in parallel. Apoptosis was analyzed as described above, besides that anti-CD4PE and anti-CD8α Cy-chrome were used to detect Annexin V binding on CD4+ and CD8+ T cells, respectively.
To further confirm the apoptotic phenotype of IEL, either freshly isolated cells or ex vivo cultured cells were harvested and stained with ethidium bromide (100 ug/ml) and acridine orange (100 ug/ml) in PBS, and immediately analyzed by fluorescence microscopy.63 In some experiments, DNA fragmentation in apoptotic IEL was detected by TUNEL using a commercially available kit (Roche Diagnostics (Rotkreuz, Switzerland).
RT-PCR for Bcl-2, Bcl-xL, cIAP-1 and cIAP-2
In some experiments, IEL or spleen cells were left either untreated or stimulated for 5 h with plate-bound anti-CD3. After two washes in PBS, cells were lysed in Tri-reagent RNA isolation medium (Sigma) and total RNA was isolated as recommended by the manufacturer. cDNA was synthesized from 2 ug total RNA using a commercial cDNA kit (Promega, Madison, WI, USA) using oligo-dT primers and manufacturer's suggested conditions. PCR for murine Bcl-2, Bcl-xL, cIAP-1, cIAP-2 and actin as a control was performed as described previously.53,64,65,66 Following primers were used: mBcl-2 sense: 5′-AGCCCTGTGCCACCATGTGTC-3′; mBcl-2 antisense: 5′-GGCAGGTTTGTCGACCTCACT-3′; mBcl-xL sense: 5′-TAGTCCAGCCAGGGCACGT-3′; mBcl-xL antisense: 5′-GGCTGATATCATACTGCAT-3′; actin sense: 5′-TGGAATCCTGTGGCATCCATGAAAC-3′; actin antisense: 5′-TAAAACGCAGCTCAGTAACAGTCCG-3′; mcIAP-1 sense 5′-GCCATTGTCTTTTCTGTCAC-3′, mcIAP-1 antisense 5′-CTGCGTCTGCATTCTCATC-3′; mcIAP-2 sense 5′-ACCTAGTGTTCCTGTTCAGC-3′, mcIAP-2 antisense 5′-CCTTCTCCTCTTCTCTTCTCTC-3′. PCR was performed in a PTC-100 thermocycler (MJ Research Inc., Watertown, MA, USA). Bcl-2, cIAP-1, cIAP-2 and actin cDNAs were amplified for 32 cycles at 1 min 94°C, 1 min 55°C, 1 min 72°C, followed by 10 min extension at 72°C; Bcl-xL cDNA was amplified for 32 cycles at 1 min 94°C, 1 min 50°C, 1 min 72°C, followed by 10 min extension at 72°C. PCR products were resolved on a 4% acrylamide-1×TBE gel and visualized by ethidium bromide staining.
Detection of cIAP-1 and XIAP by Western blot
IEL were cultured for times indicated, harvested and washed in PBS. Cell pellets were then lyzed in 1×reducing SDS–PAGE sample buffer (50 mM Tris pH 6.8, 1 mM DTT, 2% SDS, 10% glycerol, 0.1% bromophenol blue). Equal amounts of protein were separated on a 12% gel and transferred to PVDF membrane. Membranes were then blocked in 5% non-fat dry milk and incubated with anti-cIAP-1, anti-XIAP (R&D Systems, Minneapolis, MN, USA) (kindly provided by S Martin) or, to assess equal loading, anti-actin (Amersham). Antibody binding was detected with appropriate horse-radish peroxidase-conjugated secondary antibodies and ECL (Amersham).
In vivo treatment of IEL with glucocorticoid and RU-486
Balb/c mice were either injected i.p. with carrier only (olive oil, Sigma), 1 mg dexamethasone (Sigma), or 1 or 10 mg of the glucocorticoid receptor antagonist mifepristone (RU-486; kindly provided by Dr. R Sitruk-Ware, Laboratoires Exelgyn, Paris, France).36 After 3 h, mice were sacrificed, and spleen cells and IEL were isolated as described above. Viability was assessed by Annexin V staining either directly after isolation or after 6 h culture with agents and stimuli indicated. The animal studies have been performed after approval by the Animal Study Review Board of the State of Bern, Switzerland.
Abbreviations
- AICD:
-
activation-induced cell death
- CD95:
-
Fas/APO-1
- CD95L:
-
CD95 ligand
- sCD95-Fc:
-
soluble CD95-human IgG1 fusion protein
- cIAP:
-
cellular inhibitor of apoptosis
- dex:
-
dexamethasone
- HBS:
-
HEPES-buffered saline
- IL:
-
interleukin
- IEL:
-
intraepithelial lymphocytes
- PMA:
-
phorbolmyristate acetate
- RT–PCR:
-
reverse transcription polymerase chain reaction
- RU-486:
-
mifepristone
- TGFβ:
-
transforming growth factor β
- TCR:
-
T cell receptor
- TNFα:
-
tumor necrosis factor α
- TUNEL:
-
TdT-mediated dUTP nick end labeling
References
Rocha B, Guy-Grand D, Vassalli P . 1995 Extrathymic T cell differentiation Curr. Opin. Immunol. 7: 235–242
Lefrancois L, Puddington L . 1995 Extrathymic intestinal T-cell development: virtual reality? Immunol. Today 16: 16–21
Beagley KW, Husband AJ . 1998 Intraepithelial lymphocytes: origins, distribution, and function Crit. Rev. Immunol. 18: 237–254
Saito H, Kanamori Y, Takemori T, Nariuchi H, Kubota E, Takahashi-Iwanaga H, Iwanaga T, Ishikawa H . 1998 Generation of intestinal T cells from progenitors residing in gut cryptopatches Science 280: 275–278
Buzoni-Gatel D, Lepage AC, Dimier-Poisson IH, Bout DT, Kasper LH . 1997 Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii J. Immunol. 158: 5883–5889
Lepage AC, Buzoni-Gatel D, Bout DT, Kasper LH . 1998 Gut-derived intraepithelial lymphocytes induce long term immunity against Toxoplasma gondii J. Immunol. 161: 4902–4908
Muller S, Buhler-Jungo M, Mueller C . 2000 Intestinal intraepithelial lymphocytes exert potent protective cytotoxic activity during an acute virus infection J. Immunol. 164: 1986–1994
Offit PA, Cunningham SL, Dudzik KI . 1991 Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection J. Virol. 65: 1318–1324
Inagaki-Ohara K, Nishimura H, Mitani A, Yoshikai Y . 1997 Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing gamma delta T cell receptor in mice Eur. J. Immunol. 27: 2885–2891
Viney JL, MacDonald TT . 1990 Selective death of T cell receptor gamma/delta+ intraepithelial lymphocytes by apoptosis Eur. J. Immunol. 20: 2809–2812
Chu CL, Chen SS, Wu TS, Kuo SC, Liao NS . 1999 Differential Effects of IL-2 and IL-15 on the Death and Survival of Activated TCRgammadelta+ Intestinal Intraepithelial Lymphocytes J. Immunol. 162: 1896–1903
Lin T, Brunner T, Tietz B, Madsen J, Bonfoco E, Reaves M, Huflejt M, Green DR . 1998 Fas ligand- mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease J. Clin. Invest. 101: 570–577
Sydora BC, Mixter PF, Holcombe HR, Eghtesady P, Williams K, Amaral MC, Nel A, Kronenberg M . 1993 Intestinal intraepithelial lymphocytes are activated and cytolytic but do not proliferate as well as other T cells in response to mitogenic signals J. Immunol. 150: 2179–2191
Vacchio MS, Ashwell JD . 1997 Thymus-derived glucocorticoids regulate antigen-specific positive selection J. Exp. Med. 185: 2033–2038
Zacharchuk CM, Mercep M, Chakraborti PK, Simons Jr SS, Ashwell JD . 1990 Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic J. Immunol. 145: 4037–4045
Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR . 1995 Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl J. Exp. Med. 182: 1545–1556
Abbas AK . 1996 Die and let live: Eliminating dangerous lymphocytes Cell 84: 655–657
Brunner T, Mueller C . 1999 Is autoimmunity coming to a Fas(t) end? Nat. Med. 5: 19–20
Lenardo MJ . 1996 Fas and the art of lymphocyte maintenance J. Exp. Med. 183: 721–724
Scaffidi C, Kirchhoff S, Krammer PH, Peter ME . 1999 Apoptosis signaling in lymphocytes Curr. Opin. Immunol. 11: 277–285
Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH . 1995 Autocrine T-cell suicide mediated by APO-1/Fas (CD95) Nature 373: 438–441
Brunner T, Mogil RJ, La Face D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR . 1995 Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas Nature 373: 441–444
Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A . 1995 Fas(CD95)/FasL interactions required for programmed cell death after T- cell activation Nature 373: 444–448
Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Scholley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH . 1995 Fas ligand mediates activation-induced cell death in human T lymphocytes J. Exp. Med. 181: 71–77
Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ . 1995 Induction of apoptosis in mature T cells by tumour necrosis factor Nature 377: 348–351
Russell JH, White CL, Loh DY, Meleedy-Rey P . 1991 Receptor-stimulated death pathway is opened by antigen in mature T cells Proc. Natl. Acad. Sci. USA 88: 2151–2155
Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, Ruckert R, Krause H, Kunzendorf U . 1997 Interleukin-15 protects from lethal apoptosis in vivo Nat. Med. 3: 1124–1128
Laky K, Lefrancois L, von Freeden-Jeffry U, Murray R, Puddington L . 1998 The role of IL-7 in thymic and extrathymic development of TCR gamma delta cells J. Immunol. 161: 707–713
Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky DK . 1996 Intestinal epithelial cells both express and respond to interleukin 15 Gastroenterology 111: 1706–1713
Murosaki S, Inagaki-Ohara K, Kusaka H, Ikeda H, Yoshikai Y . 1997 Apoptosis of intestinal intraepithelial lymphocytes induced by exogenous and endogenous glucocorticoids Microbiol. Immunol. 41: 139–148
Van Houten N, Blake SF, Li EJ, Hallam TA, Chilton DG, Gourley WK, Boise LH, Thompson CB, Thompson EB . 1997 Elevated expression of Bcl-2 and Bcl-x by intestinal intraepithelial lymphocytes: resistance to apoptosis by glucocorticoids and irradiation Int. Immunol. 9: 945–953
Van Houten N, Gasic G . 1996 Intestinal intraepithelial lymphocyte responses to glucocorticoid signaling Ann. N.Y. Acad. Sci. 778: 431–433
Ashwell JD, Lu FW, Vacchio MS . 2000 Glucocorticoids in T cell development and function* Annu. Rev. Immunol. 18: 309–345
Yang Y, Mercep M, Ware CF, Ashwell JD . 1995 Fas and activation-induced fas ligand mediate apoptosis of T cell hybridomas: inhibition of fas ligand expression by retinoic acid and glucocorticoids J. Exp. Med. 181: 1673–1682
Bissonnette RP, Brunner T, Lazarchik SB, Yoo NJ, Boehm MF, Green DR, Heyman RA . 1995 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activation Mol. Cell. Biol. 15: 5576–5585
Gonzalo JA, Gonzalez-Garcia A, Martinez-A C, Kroemer G . 1993 Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo J. Exp. Med. 177: 1239–1246
Strasser A, O'Connor L, Huang DC, O'Reilly LA, Stanley ML, Bath ML, Adams JM, Cory S, Harris AW . 1996 Lessons from bcl-2 transgenic mice for immunology, cancer biology and cell death research Behring. Inst. Mitt 101–117
Strasser A . 1995 Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms Curr. Opin. Immunol. 7: 228–234
Gross A, McDonnell JM, Korsmeyer SJ . 1999 BCL-2 family members and the mitochondria in apoptosis Genes Dev. 13: 1899–1911
Deveraux QL, Reed JC . 1999 IAP family proteins–suppressors of apoptosis Genes Dev. 13: 239–252
Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD . 2000 Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli Science 288: 874–877
Deveraux QL, Takahashi R, Salvesen GS, Reed JC . 1997 X-linked IAP is a direct inhibitor of cell-death proteases Nature 388: 300–304
Hanninen A, Harrison LC . 2000 Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model Immunol. Rev. 173: 109–119
Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET, Paul WE, Kalz SI, Love PE, Leonard WJ . 1995 Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain Immunity 2: 223–238
Lai YG, Gelfanov V, Gelfanova V, Kulik L, Chu CL, Jeng SW, Liao NS . 1999 IL-15 promotes survival but not effector function differentiation of CD8+ TCRalphabeta+ intestinal intraepithelial lymphocytes J. Immunol. 163: 5843–5850
Fukuzuka K, Edwards III CK, Clare-Salzler M, Copeland III EM, Moldawer LL, Mozingo DW . 2000 Glucocorticoid-induced, caspase-dependent organ apoptosis early after burn injury Am. J. Physiol. Regul. Integr. Comp. Physiol. 278: R1005–R1018
De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G . 1997 Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation Proc. Natl. Acad. Sci. USA 94: 13504–13509
Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato AC . 1997 I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor EMBO J. 16: 4698–4707
Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin Jr AS . 1995 Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors Mol. Cell Biol. 15: 943–953
Brostjan C, Anrather J, Csizmadia V, Stroka D, Soares M, Bach FH, Winkler H . 1996 Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis J. Biol. Chem. 271: 19612–19616
Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M . 1995 Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis [see comments] Science 270: 286–290
Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF . 1998 IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival Science 281: 998–1001
Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS . 1998 NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation Science 281: 1680–1683
Khoshnan A, Tindell C, Laux I, Bae D, Bennett B, Nel AE . 2000 The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes J. Immunol. 165: 1743–1754
Wang CY, Mayo MW, Baldwin Jr AS . 1996 TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB Science 274: 784–787
Beg AA, Baltimore D . 1996 An essential role for NF-kappaB in preventing TNF-alpha-induced cell death [see comments] Science 274: 782–784
Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM . 1996 Suppression of TNF-alpha-induced apoptosis by NF-kappaB Science 274: 787–789
Beauparlant P, Hiscott J . 1996 Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis Cytokine Growth Factor Rev. 7: 175–190
Wilckens T, De Rijk R . 1997 Glucocorticoids and immune function: unknown dimensions and new frontiers Immunol. Today 18: 418–424
Mueller C, Corazza N, Trachsel-Loseth S, Eugster HP, Buhler-Jungo M, Brunner T, Imboden MA . 1999 Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo J Biol Chem. 274: 38112–38118
Brunner T, Yoo NJ, La Face D, Ware CF, Green DR . 1996 Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506 Int Immunol. 8: 1017–1026
Corazza N, Muller S, Brunner T, Kagi D, Mueller C . 2000 Differential contribution of Fas- and perforin-mediated mechanisms to the cell-mediated cytotoxic activity of naive and in vivo-primed intestinal intraepithelial lymphocytes J Immunol. 164: 398–403
McGahon AJ, Martin SJ, Bissonnette RP, Mahboubi A, Shi Y, Mogil RJ, Nishioka WK, Green DR . 1995 The end of the (cell) line: methods for the study of apoptosis in vitro Methods Cell Biol. 46: 153–185
Genestier L, Kasibhatla S, Brunner T, Green DR . 1999 Transforming growth factor beta1 inhibits fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc [In Process Citation] J. Exp. Med. 189: 231–239
Spanaus KS, Schlapbach R, Fontana A . 1998 TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and downmodulation of Bcl-2 and Bcl-xL Eur. J. Immunol. 28: 4398–4408
Kirman I, Zhao K, Wang Y, Szabo P, Telford W, Weksler ME . 1998 Increased apoptosis in bone marrow pre-B cells in old mice associated with their low number Int. Immunol. 10: 1385–1392
Acknowledgements
The authors would like to thank C Mueller, SJ Martin, and B Cenni for helpful discussion, precious advice on experiments and the manuscript, C Vallan for help with flow cytometry, N Corazza, S Müller, I Vogt, C Frey and M Bühler-Jungo for technical help and advice on the experiments, C Murtin for help with the RT–PCR, R Sitruk-Ware for providing RU-486, DR Green and A Mahboubi for sCD95-Fc, SJ Martin for antibodies, JA Laissue, K Brunetta Brunner and F Brunner for support. This work was supported by grants from the Swiss National Science Foundation (31-54079.98) and Swiss Cancer League (SKL 617-2-98) to T Brunner.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by L Fesus
Rights and permissions
About this article
Cite this article
Brunner, T., Arnold, D., Wasem, C. et al. Regulation of cell death and survival in intestinal intraepithelial lymphocytes. Cell Death Differ 8, 706–714 (2001). https://doi.org/10.1038/sj.cdd.4400854
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400854
Keywords
This article is cited by
-
Eight influenza virus cellular manipulations which can boost concurrent SARS-CoV-2 infections to severe outcomes
Human Cell (2023)
-
The many faces of tumor necrosis factor signaling in the intestinal epithelium
Genes & Immunity (2019)
-
Co-culture with intestinal epithelial organoids allows efficient expansion and motility analysis of intraepithelial lymphocytes
Journal of Gastroenterology (2016)
-
Colon cancer cells produce immunoregulatory glucocorticoids
Oncogene (2011)
-
Extra-adrenal glucocorticoid synthesis in the intestinal epithelium: more than a drop in the ocean?
Seminars in Immunopathology (2009)